These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33414372)

  • 1. Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
    Chen B; Zhang Y; Dai S; Zhou P; Luo W; Wang Z; Chen X; Cheng P; Zheng G; Ren J; Yang X; Li W
    Signal Transduct Target Ther; 2021 Jan; 6(1):6. PubMed ID: 33414372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.
    Wu YX; Zhang WL; Wang TM; Liao Y; Zhang YJ; Xiao RW; Jia YJ; Wu ZY; Deng CM; Yang DW; Xue WQ; He YQ; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Zhang JB; Jia WH
    J Virol; 2022 Feb; 96(4):e0169321. PubMed ID: 34908446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden.
    Wu Q; Wang W; Zhou P; Fu Y; Zhang Y; Shao YW; Jiang L
    Pathol Res Pract; 2020 Aug; 216(8):153043. PubMed ID: 32703503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.
    Zhong YM; Yin K; Chen Y; Xie Z; Lv ZY; Yang JJ; Yang XN; Zhou Q; Wang BC; Zhong WZ; Gao LL; Zhou WB; Chen J; Tu HY; Liao RQ; Zhang DK; Zhang SL; Lu DX; Zheng HB; Zhang HH; Wu YL; Zhang XC
    Front Immunol; 2022; 13():951817. PubMed ID: 36263036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study.
    Zhou Y; Huang J; Lan J; Hu H; Yuan Z; Dong L; Deng H; Yue LA; Xiao Y; Yang X
    J Cancer Res Ther; 2023 Aug; 19(4):1011-1018. PubMed ID: 37675730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-exome Sequencing of Epstein-Barr Virus-associated Pulmonary Carcinoma With Low Lymphocytic Infiltration Shows Molecular Features Similar to Those of Classic Pulmonary Lymphoepithelioma-like Carcinoma: Evidence to Support Grouping Together as One Disease Entity.
    Yeh YC; Ho HL; Lin CI; Chou TY; Wang YC
    Am J Surg Pathol; 2021 Nov; 45(11):1476-1486. PubMed ID: 33927156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.
    Yin K; Feng HB; Li LL; Chen Y; Xie Z; Lv ZY; Guo WB; Lu DX; Yang XN; Yan WQ; Wu YL; Zhang XC
    Thorac Cancer; 2020 Feb; 11(2):346-352. PubMed ID: 31794146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma.
    Hong S; Liu D; Luo S; Fang W; Zhan J; Fu S; Zhang Y; Wu X; Zhou H; Chen X; Chen G; Zhang Z; Zheng Q; Li X; Chen J; Liu X; Lei M; Ye C; Wang J; Yang H; Xu X; Zhu S; Yang Y; Zhao Y; Zhou N; Zhao H; Huang Y; Zhang L; Wu K; Zhang L
    Nat Commun; 2019 Jul; 10(1):3108. PubMed ID: 31311932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
    Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
    Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
    Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ
    Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of baseline Epstein-Barr virus DNA for recurrent or metastatic primary pulmonary lymphoepithelioma-like carcinoma.
    Zou Q; Luo K; Kang L; Huang C; Mai J; Lin Y; Liang Y
    Future Oncol; 2023 Dec; 19(37):2481-2492. PubMed ID: 38054449
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review.
    Hu Y; Ren S; Liu Y; Han W; Liu W
    Onco Targets Ther; 2020; 13():3921-3929. PubMed ID: 32494151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
    Zhao H; Chen J
    Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocytes-based subtypes and genomic characteristics of EBV-associated lymphoepithelioma-like carcinoma.
    Yin W; Jin J; Bao H; Chen H; Wang C; Cheng G; Wu C; Wu M; Yan J; Wu X; Shao Y; Ni X; Su D
    J Pathol; 2022 Aug; 257(5):650-662. PubMed ID: 35451500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma.
    Zhong YM; Chen J; Jiang J; Zhou WB; Gao LL; Zhang SL; Yan WQ; Chen Y; Zhang DK; Lu DX; Lv ZY; Xie Z; Huang Y; Guo WB; Wang BC; Yang JJ; Yang XN; Wu YL; Zhang XC
    Clin Transl Immunology; 2024; 13(6):e1515. PubMed ID: 38835955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CT and PET/CT findings in primary pulmonary lymphoepithelioma-like carcinoma with pathological correlation: a study of 215 cases.
    Lei Y; Zhou J; Liu J; Xia X; Wang P; Peng Y; Xie X; Liao Y; Wan Q; Li X
    Clin Radiol; 2022 Mar; 77(3):e201-e207. PubMed ID: 35012737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.
    Qin Y; Gao G; Xie X; Zhu Z; Guan W; Lin X; Xie Z; Ming O; Chen R; Zhong N; Li S; Zhou C
    Clin Lung Cancer; 2019 May; 20(3):e329-e337. PubMed ID: 30683631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
    Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
    Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.